Research Article
Volume 10 Issue 11 - 2021
Is Hydroxychloroquine “The Silver Bullet”? Role in Healthcare Workers as a Prophylactic Agent against Covid-19
Desh Deepak1*, Gowtham Reddy2, Amit Suri3, Kushagar Garg4 and Minakshi Bhardwaj5
1Senior Respiratory Physician, Department of Respiratory Medicine, Dr Ram Manohar Lohia Hospital and Atal Bihari Vajpayee Institute of Medical Sciences, New Delhi, India
2Resident, Department of Medicine, Dr Ram Manohar Lohia Hospital and Atal Bihari Vajpayee Institute of Medical Sciences, New Delhi, I
3Head, Department of Respiratory Medicine, Dr Ram Manohar Lohia Hospital and Atal Bihari Vajpayee Institute of Medical Sciences, New Delhi, India
4Resident, Department of Respiratory Medicine, Dr Ram Manohar Lohia Hospital and Atal Bihari Vajpayee Institute of Medical Sciences, New Delhi, India
5Consultant, Department of Pathology, Dr Ram Manohar Lohia Hospital and Atal Bihari Vajpayee Institute of Medical Sciences, New Delhi, India
*Corresponding Author: Desh Deepak, Senior Respiratory Physician, Department of Respiratory Medicine, Dr Ram Manohar Lohia Hospital and Atal Bihari Vajpayee Institute of Medical Sciences, New Delhi, India.
Received: October 14, 2021; Published: October 27, 2021


Background and Objectives: Based on the in-vitro studies Hydroxychloroquine sulphate (HCQS) was proposed as a potential therapeutic and prophylactic agent for Covid-19. We conducted a study to evaluate the role of HCQS as a prophylactic agent for Covid-19 among health care workers (HCW).

Methods: HCQS was offered to the HCWs of a tertiary care hospital catering both to Covid and non-Covid patients as a prophylactic agent. HCWs could choose to take or not take HCQS. Cross-sectional questionnaire based online survey was conducted among HCWs to study the HCQS usage and occurrence of covid19. Participants were grouped into HCQ (HCQS users) and non-HCQ (those who did not take HCQS) groups. The two groups were then compared for the occurrence of Covid-19.

Results: Out of 515 health care workers, 278 (54%) used tab HCQS while 237 (46%) did not take it at all. Of those who took, 218 (78% of HCQS users, 42% of total subjects) took HCQS regularly, while 60 (22% of HCQS users, 12% of total) used it irregularly. Out of 515 patients, 22 contracted Covid-19, 15 were HCQS users and 7 were not. No significant association between HCQS use and COVID-19 occurrence was found in our study.

Interpretations and Conclusion: Around half of the healthcare workers used HCQS for prophylaxis of Covid-19. There was no significant difference in the covid-19 positivity among HCQS and non HCQS group; however, the numbers are small for conclusive evidence. As HCQS is known to help in reducing the cytokine storm, the possibility that it helped in controlling the severity of disease cannot be ruled out based on this study. Definitive data from larger randomized controlled trials from a wide array of population groups would be helpful in the forthcoming future with regard to risk-benefit assessment and rational use of HCQS.

Keywords: COVID-19; Hydroxychloroquine Sulphate; Healthcare Workers; Pre-Exposure Prophylaxis


  1. Zhu N., et al. “A Novel Coronavirus from Patients with Pneumonia in China, 2019”. The New England Journal of Medicine 382 (2020): 727-733.
  2. World Health Organization. WHO (COVID-19) Homepage (2021).
  3. Wang M., et al. “Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro”. Cell Research (2020).
  4. RECOVERY Collaborative Group Horby P., et al. “Dexamethasone in Hospitalized Patients with Covid-19-Preliminary Report”. The New England Journal of Medicine 8 (2021): 693-704.
  5. Beigel JH., et al. “Remdesivir for the Treatment of Covid-19-Final Report”. The New England Journal of Medicine 383 (2020): 1813-1826.
  6. Cao B., et al. “A Trial of Lopinavir-ritonavir in Adults Hospitalized with Severe Covid-19”. The New England Journal of Medicine 382 (2020): 1787-1799.
  7. Caly L., et al. “The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro”. Antiviral Research 178 (2020): 104787.
  8. Calder PC., et al. “Optimal Nutritional Status for a Well-Functioning Immune System Is an Important Factor to Protect against Viral Infections”. Nutrients 4 (2020): 1181.
  9. Oldenburg CE and Doan T. “Azithromycin for severe COVID-19”. Lancet 10256 (2020): 936-937.
  10. Yates PA., et al. “Doxycycline treatment of high-risk COVID-19-positive patients with comorbid pulmonary disease”. Therapeutic Advances in Respiratory Disease 14 (2020): 1753466620951053.
  11. Liu J., et al. “Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro”. Cell Discovery 6 (2020): 16.
  12. Gao J., et al. “Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies”. BioScience Trends 14 (2020): 72-73.
  13. Https://
  14. Abella BS., et al. “Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial”. JAMA Internal Medicine 181 (2021): 195-202.
  15. Rajasingham R., et al. “Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: A randomized trial”. Clinical Infectious Diseases 72 (2021): e835-e843.
  17. Boulware DR., et al. “Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19”. The New England Journal of Medicine 383 (2020): 517-525.
  18. Nina PB and Dash AP. “Hydroxychloroquine as prophylaxis or treatment for COVID-19: What does the evidence say?” Indian Journal of Public HealthS2 (2020): 125-127.
  19. Shah S., et al. “A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease-19 (COVID-19)”. International Journal of Rheumatic Diseases 23 (2020): 613-619.
  20. De Barros CM., et al. “COVID-19 Pandemic - A Narrative Review of the Potential Roles of Chloroquine and Hydroxychloroquine”. Pain Physician 23 (2020): S351-S366.
  21. Shah RR. “Chloroquine and hydroxychloroquine for COVID-19: Perspectives on their failure in repurposing”. Journal of Clinical Pharmacy and Therapeutics1 (2021): 17-27.
  22. Monti M., et al. “Hydroxychloroquine as Prophylaxis for COVID-19: A Review”. Frontiers in Pharmacology 11 (2020): 605185.
Citation: Desh Deepak., et al. “Is Hydroxychloroquine “The Silver Bullet”? Role in Healthcare Workers as a Prophylactic Agent against Covid-19”. EC Pulmonology and Respiratory Medicine 10.11 (2021): 02-10.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

March Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the March issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before April 07, 2023.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.